title: [beta 2-Adrenomimetics before and after extracorporeal lithotripsy].
abstract: Successful disintegration of the calculus in nephrolithiasis patients is impossible without normalization of the upper urinary tracts urodynamics in dyskinesia. We employ combined treatment with high-selective beta-2-adrenomimetic hexoprenalin (hinipral) to improve migration of the concrement fragments and therefore to prevent ureteral occlusion, acute pyelonephritis and renal colic. Hexoprenalin (hinipral) is taken 6 tablets a day or intravenously in drops (5 ml per 100 ml of saline) 3-5 days before and for 10-12 days after extracorporeal shock-wave lithotripsy. Adjuvant use of hexoprenalin in combined treatment of nephrolithiasis complicated by ureteropelvic dysfunction allows effective conduction of lithotripsy.
authors.forename: Iu A
authors.initials: IuA
authors.lastname: Pytel'
authors.forename: D M
authors.initials: DM
authors.lastname: Rapoport
authors.forename: V I
authors.initials: VI
authors.lastname: Rudenko
authors.forename: A V
authors.initials: AV
authors.lastname: Chaban
mesh_terms: D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D000328:Adult; D003131:Combined Modality Therapy; D000075202:Contraindications; D006594:Hexoprenaline / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D007668:Kidney / Q000000981:diagnostic imaging; D007669:Kidney Calculi / Q000000981:diagnostic imaging / Q000628:therapy; D008096:Lithotripsy / Q000379:methods*; D008297:Male; D011859:Radiography; D013607:Tablets; D013997:Time Factors
chemical_list: D000318:Adrenergic beta-Agonists; D013607:Tablets; D006594:Hexoprenaline
vernacular_title: beta 2-Adrenomimetiki do i posle distantsionnoĭ litotripsii.